© 2025 BIOVERSE, Inc. All rights reserved.
Actual product packaging may appear differently than shown.
*Source. In a study of 1,961 non-diabetic, obese or overweight adults with weight-related medical problems, 30% of participants prescribed Wegovy® lost 20% or more weight vs. 2% of the placebo group. Participants prescribed a reduced-calorie diet, increased physical activity, and monthly nutritional counseling. Novo Nordisk oversaw, designed, and sponsored the study.
Doctor + medication included in your $159 offer. There are no hidden fees. Pay nothing until prescribed.
You'll only pay for your semaglutide treatment if your medical provider approves your request.
Your provider will guide you through the treatment and answer any questions you may have about it.
Over 90% of patients have achieved lasting weight loss.
We offer transparent pricing. Your medical visit, ongoing shipments, and provider messaging are all included in one low price.
You can now lose weight affordably
Suppress appetite & control hunger
Improve health outcome
Same active ingredient as Ozempic® & Wegovy®. No membership fees. 100% online.
*Prescription medications available only if prescribed by the healthcare provider after free online consultation. Compounded medication kits have not been approved or verified for safety or effectiveness by FDA.
Treatments that focus on the underlying factors affecting your body
from $159/month
*Source. In a study of 1,961 non-diabetic, obese or overweight adults with weight-related medical problems, 30% of participants prescribed Wegovy® lost 20% or more weight vs. 2% of the placebo group.
from $234/month
from $5/month
1
Answer a few questions about your symptoms and health history.
2
A licensed medical provider will determine if treatment is right for you.
3
Your weight loss meds will ship discreetly to you for free, if prescribed.
*Bioverse offers compounded drug products, including semaglutide and tirzepatide, which are not FDA-approved. Compounded drug products, including semaglutide and tirzepatide, are not approved or evaluated for safety, effectiveness, or quality by the FDA. These products are compounded in accordance with applicable laws and are to be used only as prescribed by a licensed healthcare provider.
*Any references to active ingredients such as semaglutide and tirzepatide being similar to those in FDA-approved products like Ozempic, Wegovy, Mounjaro, or Zepbound are intended solely to provide information about the active ingredients and are not intended to imply that our compounded products are equivalent to or interchangeable with these FDA-approved products.
*Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide), and Generic Liraglutide are not compounded. Ozempic®, Mounjaro®, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may also be prescribed for weight loss at a healthcare provider’s discretion. Wegovy® and Zepbound® are FDA-approved for weight loss.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Bioverse is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.